BioSpace News Archive

The Alzheimer Society of Canada is hopeful about the U.S. Food and Drug Administration’s (FDA) approval of aducanumab, a new treatment for Alzheimer’s disease.

Increasing vaccine confidence is a critical part of getting through the COVID-19 pandemic. As COVID-19 vaccines roll out across the country, the Public Health Agency of Canada is supporting community-driven information initiatives through its Vaccine Community Innovation Challenge.

Hoth Therapeutics, Inc. (NASDAQ: HOTH), today announced that it has entered into a Sponsored Research Agreement with Washington University in St. Louis to support the continued research and development of HT-ALZ, a novel therapeutic for the treatment of symptoms related to Alzheimer’s disease.

Convey Holding Parent, Inc., today announced it has launched the roadshow for the initial public offering of 13,333,334 shares of its common stock, with 11,666,667 shares to be offered by the Company and 1,666,667 shares to be offered by a selling stockholder pursuant to a registration statement filed on Form S-1 with the Securities and Exchange Commission (the “SEC”

Hawaii Biotech, Inc., a privately held technology company that develops vaccines and biodefense drugs, announced that Elliot Parks, Ph.D., president and chief executive officer, is retiring for medical reasons.

Design Therapeutics, Inc. (Nasdaq: DSGN), today announced the appointments of industry veterans, Heather Behanna, Ph.D., principal of SR One, and Deepa Prasad, managing director of WestRiver Group, to its board of directors effective June 15, 2021.

Histogen Inc. (Nasdaq: HSTO), today announced that it has entered into definitive agreements with several institutional and accredited investors, for the purchase and sale of 5,977,300 shares of its common stock,

Novavax, Inc. (Nasdaq: NVAX), today announced that Stanley C. Erck, President and Chief Executive Officer, will participate in a panel discussion at the BIO International Convention 2021 on June 14

bluebird bio, Inc. (NASDAQ: BLUE) today announced that members of the management team will participate in the Goldman Sachs 42nd Annual Global Healthcare Conference.

Centessa Pharmaceuticals plc (Nasdaq: CNTA) announced today that Saurabh Saha, M.D., Ph.D., Chief Executive Officer, will participate in an analyst-led fireside chat at the Goldman Sachs 42nd Annual Global Healthcare Conference